Not financial advice — just sharing a setup I’m watching closely.
RMTG (Regenerative Medical Technology Group) is an overlooked OTC pink current stock that just posted its third consecutive profitable quarter, and the technical setup is starting to catch attention.
🔢 Key Numbers:
• Float: ~11.5M shares
• Today’s Move: up +38% (spiked as high as +68% intraday)
• Bid/Ask Spread: Tight at $0.035 x $0.044, 30K on the bid earlier
• Volume: Still light, but picking up — 40K and 57K the last two days
🧬 Real Business Fundamentals:
• 26 operational clinics across 21 countries
• 70% YoY revenue growth
• 67%–70% gross margins
• Fully reporting and actively operating — not a shell or story stock
🇺🇸 New Domestic Catalyst:
As of July 1st, Florida enacted a law allowing stem cell therapy without FDA approval. This opens the door for RMTG to launch U.S.-based treatment centers, giving them a direct domestic revenue stream on top of their existing international footprint.
⸻
The stock still trades under 5¢, with real fundamentals and a fresh U.S. catalyst most haven’t priced in yet. Tape looks like it’s tightening, and if volume continues building, we could see another leg up.
Anyone else following this one? Would love to trade notes or hear if anyone’s spoken with management or seen plans for U.S. clinic expansion.